Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To get the patent status of key drugs
— Marketing manager, Chile
To get information on international drug patents
— Patent agent, USA
To have more information regarding the patents and generic products available
— Project manager, bioequivalence studies, Brazil
For competitive information on the pharmaceutical industry
— Business intelligence, USA
To get information on when drug patents are set to expire or have expired
— Journalist, UK
Generated: May 26, 2017
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sunovion Pharms Inc | UTIBRON | glycopyrrolate ; indacaterol maleate | POWDER;INHALATION | 207930 | NDA | Novartis Pharmaceuticals Corporation | 0078-0664-06 | 6 CAPSULE in 1 BOX, UNIT-DOSE (0078-0664-06) | |||||||||||||||||||||
Sunovion Pharms Inc | UTIBRON | glycopyrrolate ; indacaterol maleate | POWDER;INHALATION | 207930 | NDA | Novartis Pharmaceuticals Corporation | 0078-0664-19 | 60 BLISTER PACK in 1 BOX, UNIT-DOSE (0078-0664-19) > 1 CAPSULE in 1 BLISTER PACK (0078-0664-61) | |||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
To conduct drug patent landscape analysis
— Pharmaceutical R&D, China
To obtain patent expiration information, so that the timeline for registration and launch of our generic products can be optimized.
— Business development manager, generics distribution company, Singapore
To get reliable data on drug patent information
— CFO, Pharmaceuticals, Singapore
To obtain the latest patent expiry data
— Pharmaceutical company sales director, Pakistan
To identify branded drug patent expiration and generic market entry
— CRO project manager, Portugal
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
